Schizophrenia News and Research

Latest Schizophrenia News and Research

New scanning methods could help predict people vulnerable to schizophrenia

New scanning methods which map the wiring of the brain could provide a valuable new tool to predict people at risk of schizophrenia, according to a new study.

11 May 2015

Non-suicidal self-injury common among Iraq and Afghanistan veterans

Non-suicidal self-injury--that is, purposefully hurting oneself without conscious suicidal intent--is relatively common among Iraq and Afghanistan veterans, according to a study published online April 1, 2015, in Psychiatry Research.

10 May 2015

Study finds link between PTSD and accelerated aging

In recent years, public health concerns about post-traumatic stress disorder (PTSD) have risen significantly, driven in part by affected military veterans returning from conflicts in the Middle East and elsewhere. PTSD is associated with number of psychological maladies, among them chronic depression, anger, insomnia, eating disorders and substance abuse.

10 May 2015

Brandeis University researchers discover brain abnormality responsible for schizophrenic symptoms

Schizophrenia affects millions of people worldwide but the cause of its wide-ranging symptoms remains largely unknown.

8 May 2015

NIMH-funded project aims to identify genetic causes of schizophrenia

Researchers at the University of Virginia School of Medicine will seek to identify the genetic causes of schizophrenia as part of a major project funded by the National Institute of Mental Health to better understand how genetic variation in brain cells affects human health and disease.

7 May 2015

Common electric brain stimulation has significant detrimental effect on IQ scores

Using a weak electric current in an attempt to boost brainpower or treat conditions has become popular among scientists and do-it-yourselfers, but a new University of North Carolina School of Medicine study shows that using the most common form of electric brain stimulation had a statistically significant detrimental effect on IQ scores.

6 May 2015

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

Indivior PLC today announced top-line results from its phase 3 clinical trial of RBP-7000, an investigational drug in development for the treatment of schizophrenia. In this pivotal study, both doses of RBP-7000 tested, 90 mg and 120 mg administered once-monthly, met the primary endpoint with statistically and clinically significant reductions in the symptoms of acute schizophrenia over an 8-week treatment period.

5 May 2015

New study shows that depression can make your brain go 'fuzzy'

People with depression or bipolar disorder often feel their thinking ability has gotten "fuzzy", or less sharp than before their symptoms began. Now, researchers have shown in a very large study that effect is indeed real - and rooted in brain activity differences that show up on advanced brain scans.

5 May 2015

Children bullied by peers face worse long-term mental health problems than those who are maltreated

A new study published in The Lancet Psychiatry shows that children who have been bullied by peers suffer worse in the longer term than those who have been maltreated by adults.

28 Apr 2015

New study finds high mortality risks from alcohol and drug abuse among ex-prisoners

Alcohol and drug misuse are responsible for around a third of all deaths in former male prisoners and half in female ex-prisoners, a new study of almost 48000 ex-prisoners published in The Lancet Psychiatry journal has found. Moreover, the research shows that a substantial proportion of these deaths are from preventable causes, including accidents and suicide (42% in men and 70% in women).

24 Apr 2015

Two existing drugs may reverse damage caused by multiple sclerosis

A pair of topical medicines already alleviating skin conditions each may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis.

21 Apr 2015

TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes

According to the World Health Organization, more than 21 million people worldwide suffer from schizophrenia, a severe psychiatric disorder that can cause delusions and hallucinations and lead to increased risk of suicide...

8 Apr 2015

Study: 9% of U.S. adults have impulsive, angry behavior and have access to guns

An estimated 9 percent of adults in the U.S. have a history of impulsive, angry behavior and have access to guns, according to a study published this month in Behavioral Sciences and the Law. The study also found that an estimated 1.5 percent of adults report impulsive anger and carry firearms outside their homes.

8 Apr 2015

Scientists identify brain molecule that triggers schizophrenia-like behaviors, brain changes

Scientists at The Scripps Research Institute have identified a molecule in the brain that triggers schizophrenia-like behaviors, brain changes and global gene expression in an animal model. The research gives scientists new tools for someday preventing or treating psychiatric disorders such as schizophrenia, bipolar disorder and autism.

8 Apr 2015

Antipsychotic drugs may elevate child's risk for weight gain, type II diabetes

Today in JAMA Pediatrics, researchers from The Children's Hospital of Philadelphia's (CHOP) PolicyLab published the largest study to date documenting the significant risks to children's health associated with prescription antipsychotics, a powerful a class of medications used to treat mental and behavioral health disorders.

7 Apr 2015

Mouse model may help understand the physiology behind complex brain disorders

Complex brain disorders, such as autism or schizophrenia, still puzzle scientists because their causes lie hidden in early events of brain development, which are still poorly understood.

3 Apr 2015

Omeros announces commercial availability of Omidria in U.S.

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, announced today the nationwide commercial availability of Omidria (phenylephrine and ketorolac injection) 1%/0.3%.

2 Apr 2015

Purdue researchers identify new class of chemical insecticides to control mosquitoes

Purdue researchers have identified a new class of chemical insecticides that could provide a safer, more selective means of controlling mosquitoes that transmit key infectious diseases such as dengue, yellow fever and elephantiasis.

2 Apr 2015

Long-term effects of using cognitive-enhancing drugs by healthy people need to be determined

The government, pharmaceutical industry, and national medical organisations need to work together to look at the harms and benefits of long-term use of cognitive-enhancing drugs by healthy individuals, say neuroscientists Professor Barbara Sahakian and Dr Sharon Morein-Zamir from the University of Cambridge in the UK, writing in a Personal View in The Lancet Psychiatry journal.

2 Apr 2015

Antibodies may trigger psychiatric illness in children

A world first study revealing the presence of two antibodies in a sub-group of children experiencing their first episode of psychosis affirms a longstanding recognition that auto-immune disorders play a significant role in psychiatric illness.

31 Mar 2015

Schizophrenia News and Research

Latest Schizophrenia News and Research

New scanning methods could help predict people vulnerable to schizophrenia

Non-suicidal self-injury common among Iraq and Afghanistan veterans

Study finds link between PTSD and accelerated aging

Brandeis University researchers discover brain abnormality responsible for schizophrenic symptoms

NIMH-funded project aims to identify genetic causes of schizophrenia

Common electric brain stimulation has significant detrimental effect on IQ scores

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

New study shows that depression can make your brain go 'fuzzy'

Children bullied by peers face worse long-term mental health problems than those who are maltreated

New study finds high mortality risks from alcohol and drug abuse among ex-prisoners

Two existing drugs may reverse damage caused by multiple sclerosis

TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes

Study: 9% of U.S. adults have impulsive, angry behavior and have access to guns

Scientists identify brain molecule that triggers schizophrenia-like behaviors, brain changes

Antipsychotic drugs may elevate child's risk for weight gain, type II diabetes

Mouse model may help understand the physiology behind complex brain disorders

Omeros announces commercial availability of Omidria in U.S.

Purdue researchers identify new class of chemical insecticides to control mosquitoes

Long-term effects of using cognitive-enhancing drugs by healthy people need to be determined

Antibodies may trigger psychiatric illness in children

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Schizophrenia News and Research

Latest Schizophrenia News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in